1Okudaira H, Mori A. Concepts of the pathogenesis of allergic disease: possible roles of Epstein-Barr virus infection and interleukin-2 production. Int Arch Allergy Immunol,1999 Nov;120(3):177～84.
2Glezen WP,Greenberg SB, Atmar RL,et al. Impact of respiratory virus infections on persons with chronic underlying conditions.Jama2000 Jan 26:283(4) :499～505.
4Gern JE,Vrtis R,Kelly EA,et al. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism,J Immunol 1996,Aug,15:157 * 4):1605～12.
5Martinez FD, Stern DA, Wright Al,et al. Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allegry clin Immunol,1998,Dec;102(6):915～20.
6Bjornsson E,Hjelm E,Janson C,et al. Serology of respiratory viruses in relation to sathma and bronchial hyperresponsiveness. Ups J Med Sci1996; 101 ( 2 ): 159～ 68.
7Tekkanat KK,Maassab HF,Vho DS,et al. IL-13-inducd airway hyperrcactivity during respiratory syncytial virus infection is stat6 dependent. J Immunol 2001 Mar 1;166(5):3542～8.
8Schwarze J,Cieslewicz G,Hamelmann E,et al. IL-5 and eosinophils are essential for the development of airway heperresponsiveness following acute respiratory syncytial virus infection. J Immunol, 1999mar 1;162(5):2997～3004.
9Tripp RA,Moore D, Winter J,et al. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P,which mediated inflammation and enhanced pulmonary disease in BALB/c mice. J Virol 2000 Fed;74(4):1614～22.
10Suzuki S,Suzuki Y,Yamamoto N,et al. Influenza A virus infection increases IgE production and airway responsiveness in aerosolized antigen-exposed mice. J Allergy Clin Immunol, 1998, Nov; 102 (5):732～40.
